TAVR with a Balloon-Expandable Valve in Low-Risk Patients

Transcatheter Aortic-Valve Replacement (TAVR) with a Balloon-Expandable Valve in Low-Risk Patients
At 71 centers, 1000 patients underwent randomization.
Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery. 
Author(s)Source
Mack MJ et al.The New England Journal of Medicine, March 16, 2019, DOI: 10.1056/NEJMoa1814052
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know
Scroll to Top